Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$15.08 - $38.61 $13,722 - $35,135
-910 Reduced 52.75%
815 $30,000
Q3 2022

Oct 17, 2022

SELL
$33.44 - $56.56 $1,504 - $2,545
-45 Reduced 2.54%
1,725 $61,000
Q2 2022

Aug 02, 2022

BUY
$26.2 - $54.0 $786 - $1,620
30 Added 1.72%
1,770 $62,000
Q4 2021

Feb 14, 2022

SELL
$75.47 - $135.88 $27,169 - $48,916
-360 Reduced 17.14%
1,740 $134,000
Q3 2021

Oct 29, 2021

SELL
$95.64 - $131.48 $32,517 - $44,703
-340 Reduced 13.93%
2,100 $226,000
Q1 2021

May 11, 2021

BUY
$105.48 - $207.97 $181,953 - $358,748
1,725 Added 241.26%
2,440 $303,000
Q4 2020

Feb 05, 2021

SELL
$76.64 - $167.89 $6,514 - $14,270
-85 Reduced 10.63%
715 $101,000
Q3 2020

Oct 30, 2020

BUY
$45.46 - $78.79 $36,368 - $63,032
800 New
800 $60,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.55B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.